Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Volati’s Nomination Committee’s proposals for AGM 2021

The Nomination Committee of Volati AB (publ) has decided to propose re-election of Board members Anna-Karin Celsing, Björn Garat, Louise Nicolin, Karl Perlhagen, Magnus Sundström, Christina Tillman and Patrik Wahlén. The Committee also proposes the re-election of Patrik Wahlén as Chairman of the Board and the re-election of Ernst & Young Aktiebolag as auditor until the end of the next annual general meeting. Information about the Board members proposed for re-election can be found on Volati’s website, www.volati.se. The Nomination Committee consists of Carin Wahlén (chair,

Finnair shows green light to electric flying, signs letter of interest on electric aircraft developed by Heart Aerospace

Finnair has signalled its interest for electric aviation as a force to be reckoned with for future flying, signing a Letter of Interest for Heart Aerospace's Electric ES-19 electric aircraft, which is currently under development.    Finnair could acquire up to 20 of the new 19-seater Heart Aerospace ES-19 electric aircraft, for use on the airline’s short routes. According to Heart Aerospace, the aircraft are expected to be available for first commercial flights in 2026.   Anne Larilahti, Finnair Vice President of Sustainability, said: “Finnair believes electric aviation will be one of

I.A.R. Systems Group AB Annual Report 2020

The Board of Directors and the CEO of I.A.R. Systems Group AB hereby present the annual report for I.A.R. Systems Group AB and the I.A.R. Systems Group for the financial year 2020. If you would like to receive the annual report in printed form, please send an email to josefin.skarin@iar.com. This information is information that I.A.R. Systems Group is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication at 10:00 CET on 2021-03-25.

Cederquist advises on the IPO of the first SPAC in Sweden

Cederquist is legal advisor to ACQ Bure AB (publ), a Swedish acquisition company, so-called SPAC (Special Purpose Acquisition Company), in connection with its initial public offering and listing on Nasdaq Stockholm, raising approx. SEK 3.5 billion. ACQ Bure AB has been established on the initiative of the investment company Bure Equity AB and is the first SPAC in Sweden. The listing is conducted under the new rules of Nasdaq Stockholm for SPACs, which entered into force on 1 February. SPACs are a phenomenon which have become increasingly common in the US. The SPAC raises capital and is

BioStock Studio: Gabather gives clinical trial update

Gabather’s top candidate GT-002 for treating psychiatric or mood disorders like depression, anxiety, and schizophrenia is currently in the early stages of clinical development. The company is planning a key target engagement study in healthy volunteers aimed at showing how GT-002 modulates brain activity at both the functional and regional levels of the brain. The company's CEO Michael-Robin Witt joined BioStock via link to tell us more about GT-002 and give us an update on the ongoing clinical trial.Watch the interview with Gabather's CEO Michael-Robin Witt at biostock.se:  https://www.

Annual report for 2020 is published today

SpareBank 1 SR-Banks annual report for 2020 and Pillar III-report for 2020 are published today, on the group’s website www.sr-bank.no under “Investor Relations”.Contact people:Inge Reinertsen, CFO, Tel. +47 909 95 033 Stian Helgøy, Vice President Investor Relations, Tel. +47 906 52 173 Thor-Christian Haugland, Executive Vice President Communications, Tel. +47 480 31 633 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Shawbrook Bank Recognised Twice in MoneyComms ‘Top Performers 2021’ List

· The specialist bank has been named ‘Best Personal Loans Provider’ and ‘Best Business Savings Provider of the Year’ · MoneyComms, now in its 9[th] year, monitors and analyses personal and business finance products, rates and trends across a range of industriesLONDON: 25/03/21 Shawbrook Bank has been recognised twice in the latest ‘Top Performers’ list by MoneyComms. The specialist bank – which serves UK-based consumers and businesses – has been named ‘Best Personal Loan Provider’ and ‘Best Business Savings Provider’ of the year. Shawbrook’s products were assessed against its

TFS HealthScience Standardizes on Veeva Vault Clinical Operations Suite to Accelerate Clinical Development

Veeva Vault unifies clinical documents and processes to improve collaboration and speed execution Veeva Systems  (NYSE: VEEV) today announced that TFS HealthScience will be the first CRO to have selected Veeva Vault Clinical Operations Suite  for end-to-end study management on a single cloud platform. The European-headquartered global CRO is taking action to further modernize the study operations, adopting the entire suite to drive greater efficiency and speed in trials. TFS HealthScience will now be

Outokumpu to develop its supplier monitoring and transparency in sourcing

Outokumpu OyjPress releaseMarch 25, 2021 at 10.15Outokumpu to develop its supplier monitoring and transparency in sourcing Outokumpu is taking actions to further develop the monitoring of its suppliers and to increase the transparency of its sourcing. After the report of the Finnish NGO Finnwatch in February, the company has also decided to audit Vale, one of its ferronickel suppliers. ”The Finnwatch report was an important reminder of the importance of responsibility throughout Outokumpu’s supply chain. As the leading provider of sustainable stainless steel, we have set high

Vestas seals largest EnVentus order to date in Germany

News release from Vestas Northern and Central EuropeHamburg, 25 March 2021 Vestas has secured its largest EnVentus order yet in Germany, at the 39 MW Wohlsdorf project in Rotenburg, Lower Saxony. Vestas will supply seven V150-5.6 MW turbines to the project, which is located in between Bremen and Hamburg. The Wohlsdorf project is being developed by Windpark Wohlsdorf GmbH & Co. KG, a special purpose company owned by Reon and CapCerta. The project was awarded as part of the German Federal Network Agency’s (BNetzA) latest onshore wind auction rounds. The V150 EnVentus turbines in

YIT Announces Indicative Tender Offer Results for its outstanding notes due 2021 and 2023

YIT Corporation    Stock Exchange Release    25 March 2021 at 10:00 a.m.NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR SUCH OTHER COUNTRIES OR OTHERWISE IN SUCH CIRCUMSTANCES IN WHICH THE OFFERING OF THE NEW NOTES, OR THE CAPITAL SECURITIES, THE TENDER OFFER OR THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. YIT Announces Indicative Tender Offer Results for its outstanding notes due 2021 and 2023 YIT Corporation announces

Swedish tech success Regily launches Checkin.com

Tech success Regily was founded in Sweden four years ago, by former product frontmen of Klarna, with the idea of replacing the existing and often complicated online processes for signup and identification with one unified process for user onboarding, or checkin. The company has since then developed their unique SaaS offering to become the world’s leading checkin-solution, guaranteeing their partners increased conversion irrespective of the end-users  geography or device. Regily now releases the third generation software with the launch of Checkin.com.The company's unique SaaS-offering makes

Annual report 2020

Beijer Ref´s Annual Report for 2020 is now available on www.beijerref.com. The printed version will be available in April. Malmö, 25 March 2021 Beijer Ref AB (publ) For further information, please contact: Per Bertland, CEO Telephone +46 40-35 89 00 Email pbd@beijerref.com Maria Rydén, CFO Telephone +46 40-35 89 00 Email mrn@beijerref.com BEIJER REF AB is a technology-oriented trading Group which, through added-value products, offers its customers competitive solutions within refrigeration and climate control. Beijer Ref is one of the largest refrigeration

Exercise of Options

Faron Pharmaceuticals Oy (“Faron” or the “Company”) Exercise of options Issue of equity Company announcement, 25 March 2020 at 9.45 AM (EET)   TURKU, FINLAND – Faron Pharmaceuticals Oy (AIM: FARN, First North: FARON), the clinical stage biopharmaceutical company, announces that it has received a notification from Toni Hänninen, Faron’s CFO, to exercise D options over 40,000 ordinary shares in the Company at an exercise price of EUR 1.09 (approx. GBP 0.94) per share under the Company’s 2015 Option Plan (“New Ordinary Shares”). The terms and conditions of the 2015 Option

IRLAB’s drug candidate mesdopetam's mechanism of action receives confirmation by independent scientists

IRLAB (Nasdaq Stockholm: IRLAB A) announced today that independent scientists have confirmed that the dopamine D3 receptor (D3R) is a highly promising drug target with therapeutic potential in levodopa-induced dyskinesia, especially when the receptor’s unique signaling properties are taken into account. IRLAB’s mesdopetam is currently the most advanced D3R antagonist compound in the global neurology pipeline. It is used in the scientific article to exemplify a compound that could have an impact on the management of anumber of disorders marked by aberrant D3R activity. The article was

Follicum appoints new CEO and establishes new role as Chief Scientific Officer

Follicum AB announces today that the company has recruited Dr. Kim Arvid Nielsen as new CEO, taking office on April 6, 2021. He has extensive experience in business development, investor relations and drug development from leading positions in both small and large pharmaceutical companies. At the same time, Follicum is establishing a new position as Chief Scientific Officer. The changes are implemented to strengthen the company's organization to keep in step with the progress made in its pharmaceutical projects.Follicum has recently made continued progress in its pharmaceutical projects

Germany cancels hard lock-down during Easter but extended lock-down continues as announced before

Kamux Corporation    Press Release    25 March 2021 at 9:40 (EET) Germany cancels hard lock-down during Easter but extended lock-down continues as announced before Germany cancels hard lock-down during Easter which means that retail stores can be open depending on the regional incidence of infections and measures related to that. Kamux’s stores in Germany will be open according to local guidelines and restrictions. The stores can be open if the incidence of infections is low, with higher incidence of infections available will be pre-booked store appointments, click&collect option or

French hospital specialized in neuroscience chooses Sectra’s digital pathology solution to improve diagnostics

Linköping, Sweden and Paris, France – March 25, 2021 – GHU Paris psychiatrie & neurosciences has ordered a digital pathology solution from international medical imaging IT and cybersecurity company Sectra  (STO: SECT B). The digital technology will maximize workflow efficiency and improve collaboration between pathologists, pushing the limits even further within the field of neuropathology. This will ultimately lead to more accurate and faster diagnoses for patients, which is key when deciding on a suitable treatment, especially in precision medicine.“As an expert

PPG Industries, Inc. has received approval from the Ministry of Economic Affairs and Employment of Finland for the acquisition of all Tikkurila Oyj’s shares

TIKKURILA OYJTender Offer March 25, 2021 at 9.35 a.m. EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THE TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. PPG Industries, Inc. (“PPG” or the “Offeror”), a corporation incorporated under the laws of Pennsylvania, and Tikkurila Oyj (“Tikkurila” or the “Company”) have on December 18, 2020 entered into a combination agreement (the “Combination Agreement”), which was amended

Redsense signs new distributor agreement with Regional Health Care Group in Australia

Redsense Medical AB announces that the Company has signed a new exclusive distributor agreement with Regional Health Care Group (RHCG) in Australia, covering the distribution of the Redsense Alarm system to the markets of Australia and New Zealand. In addition, RHCG has shown considerable interest in a further development of the collaboration to include the Redsense Clamp accessory when it becomes available. The Redsense Clamp is currently under development, and Redsense will seek opportunities to conduct an evaluation of the system in Australia. “We are very happy to announce this

Nel ASA: Signs MoU with Haldor Topsoe for delivery of end-to-end green ammonia and methanol solutions

(Oslo, 25 March 2021) Nel ASA (Nel, OSE:NEL) has entered into an MoU with Haldor Topsoe with the intent to offer customers end-to-end green ammonia and methanol solutions, based on globally leading technologies from the two companies. "We are very excited to join forces with Haldor Topsoe for possible future development of end-to-end green ammonia and green methanol solutions to customers, both which are widely regarded as important carbon free fuels and energy carriers for the future. This is a market that is expected to grow significantly in the years to come and we look forward to

Last patient with liver cancer included in the monotherapy part of Medivir's phase Ib study with MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the last patient with advanced liver cancer has been included in the first part of the phase Ib study with MIV-818. Like the other patients in the study, the patient is dosed in cycles of three weeks starting with MIV-818 as monotherapy for five days. In parallel, the company is preparing part two of the phase Ib study to be able to begin during the second half of 2021. · It is gratifying that we this far have managed to carry out the study without any major delays despite the ongoing Covid-19 pandemic. We are

Nightingale Health Plc – Managers’ transactions – Timo Soininen

Nightingale Health Plc – Managers’ transactions – 25 March 2021 9:30 a.m. (Finnish time)Nightingale Health Plc – Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Soininen, Timo Position: Member of the Board/Deputy member Issuer: Nightingale Health Oyj LEI: 743700WUIPC24LVMLO66 Notification type: INITIAL NOTIFICATION Reference number: 743700WUIPC24LVMLO66_20210324144018_2 ____________________________________________ Transaction date: 2021-03-24 Venue: FIRST NORTH FINLAND (FNFI)

There are no items matching the current filter
There are no more items matching the current filter
Back to top